103 related articles for article (PubMed ID: 7752710)
41. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Martín A; Conde E; Arnan M; Canales MA; Deben G; Sancho JM; Andreu R; Salar A; García-Sanchez P; Vázquez L; Nistal S; Requena MJ; Donato EM; González JA; León A; Ruiz C; Grande C; González-Barca E; Caballero MD;
Haematologica; 2008 Dec; 93(12):1829-36. PubMed ID: 18945747
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis.
Le Doussal V; Coindre JM; Leroux A; Hacene K; Terrier P; Bui NB; Bonichon F; Collin F; Mandard AM; Contesso G
Cancer; 1996 May; 77(9):1823-30. PubMed ID: 8646680
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
[TBL] [Abstract][Full Text] [Related]
44. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
[TBL] [Abstract][Full Text] [Related]
45. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
Beal K; Allen L; Yahalom J
Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039
[TBL] [Abstract][Full Text] [Related]
46. [Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].
Oriol A; Ribera JM; Flores A; Batlle M; las Heras G; Vaquero M; Juncá J; Millá F; Feliu E
Med Clin (Barc); 1995 Mar; 104(8):281-6. PubMed ID: 7700086
[TBL] [Abstract][Full Text] [Related]
47. [Large cell lymphomas: effect of histologic groups on the prognosis. Study of 210 cases treated with the same therapeutic protocols].
Dumont J; Charpy-Validire P; Raphael M; Tulliez M; Le Doussal V; Barge J; Mosseri V
Arch Anat Cytol Pathol; 1992; 40(2-3):110-5. PubMed ID: 1449259
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of GST-pi expression in diffuse large B-cell lymphomas.
Ribrag V; Koscielny S; Carpiuc I; Cebotaru C; Vande Walle H; Talbot M; Fenaux P; Bosq J
Leukemia; 2003 May; 17(5):972-7. PubMed ID: 12750712
[TBL] [Abstract][Full Text] [Related]
49. Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
Nicolaides C; Fountzilas G; Zoumbos N; Skarlos D; Kosmidis P; Pectasides D; Karabelis A; Giannakakis T; Symeonidis A; Papadopoulos A; Antoniou F; Pavlidis N
Oncology; 1998; 55(5):405-15. PubMed ID: 9732217
[TBL] [Abstract][Full Text] [Related]
50. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.
Katsuya H; Yamanaka T; Ishitsuka K; Utsunomiya A; Sasaki H; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Suzumiya J; Tamura K
J Clin Oncol; 2012 May; 30(14):1635-40. PubMed ID: 22473153
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of proliferative activity of diffuse large cell lymphomas.
Kossakowska AE; Huchcroft S; Boras V; Urbanski SJ
Hematol Pathol; 1991; 5(3):101-7. PubMed ID: 1960133
[TBL] [Abstract][Full Text] [Related]
52. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
[No Abstract] [Full Text] [Related]
53. Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma.
Aviles A; Yañez J; López T; García EL; Guzmán R; Díaz-Maqueo JC
Arch Med Res; 1995; 26(1):31-4. PubMed ID: 7711444
[TBL] [Abstract][Full Text] [Related]
54. [Primary thyroid non-Hodgkin's lymphoma of Ann Arbor stages IE and IIE: prognostic factors].
Ma YQ; Cao ZW; Shi SL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr; 44(4):272-6. PubMed ID: 19558830
[TBL] [Abstract][Full Text] [Related]
55. [Angioimmunoblastic T cell lymphoma: clinical analysis of 42 cases].
Zhang C; Wang XP; Zheng W; Xie Y; Lin NJ; Ping LY; Ying ZT; Liu WP; Deng LJ; Song YQ; Zhu J
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(46):3671-4. PubMed ID: 24534347
[TBL] [Abstract][Full Text] [Related]
56. Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study.
Hedström G; Peterson S; Berglund M; Jerkeman M; Enblad G;
Acta Oncol; 2015 Jun; 54(6):924-32. PubMed ID: 25843161
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of survivin expression in diffuse large B-cell lymphomas.
Adida C; Haioun C; Gaulard P; Lepage E; Morel P; Briere J; Dombret H; Reyes F; Diebold J; Gisselbrecht C; Salles G; Altieri DC; Molina TJ
Blood; 2000 Sep; 96(5):1921-5. PubMed ID: 10961895
[TBL] [Abstract][Full Text] [Related]
58. Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.
Merli M; Visco C; Spina M; Luminari S; Ferretti VV; Gotti M; Rattotti S; Fiaccadori V; Rusconi C; Targhetta C; Stelitano C; Levis A; Ambrosetti A; Rossi D; Rigacci L; D'Arco AM; Musto P; Chiappella A; Baldini L; Bonfichi M; Arcaini L
Haematologica; 2014 Mar; 99(3):489-96. PubMed ID: 24270404
[TBL] [Abstract][Full Text] [Related]
59. [Predictive factors of the persistence of sarcoidosis activity 2 years after diagnosis].
Mañá J; Badrinas F; Manresa F; Valverde J; Fernández-Nogués F
Med Clin (Barc); 1991 Dec; 97(20):769-73. PubMed ID: 1795570
[TBL] [Abstract][Full Text] [Related]
60. [Large-cell lymphomas: the International Prognostic Index].
López Guillermo A; Montserrat E
Sangre (Barc); 1992 Oct; 37(5):329-30. PubMed ID: 1293770
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
